Hyperion Defi HYPD
NASDAQ HYPD
$3.18 +0.04 (+1.27%)
At close: Aug 21, 2026 · 4:00 PM EDT

Hyperion Defi (HYPD) Cash & Equivalents (2017 - 2026)

Hyperion Defi (HYPD) posted quarterly Cash & Equivalents of $7.4 million for Q1 2026, up 88.06% year-over-year from $3.9 million in Q1 2025, and up 14.85% quarter-over-quarter from $6.4 million in Q4 2025.

Hyperion Defi (HYPD) Cash & Equivalents (2017 - 2026) Analysis & Trends

Hyperion Defi (HYPD) has reported Cash & Equivalents for 10 consecutive years, with $7.4 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash & Equivalents rose 88.06% year-over-year to $7.4 million; the TTM figure through Mar 2026 stood at $7.4 million (up 88.06% YoY), while the FY2025 annual figure was $6.4 million, up 203.73% from the prior year.
  • Cash & Equivalents improved to $7.4 million in Q1 2026 per HYPD's latest filing, from $6.4 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $26.7 million in Q1 2022 and bottomed at $2.1 million in Q4 2024.
  • Historically, Cash & Equivalents has averaged $12.5 million across 5 years, with a median of $8.2 million in 2025.
  • Annual changes were most pronounced in 2024 — Cash & Equivalents sank 86.85% — and 2025, when it soared 227.37%.
  • Hyperion Defi's Cash & Equivalents stood at $22.9 million in 2022, then sank by 35.05% to $14.8 million in 2023, then tumbled by 85.71% to $2.1 million in 2024, then soared by 203.73% to $6.4 million in 2025, then grew by 14.85% to $7.4 million in 2026.
  • Business Quant data shows HYPD's Cash & Equivalents at $7.4 million in Q1 2026, $6.4 million in Q4 2025, and $8.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 3.58 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 1.72 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.71 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 8.93 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 544.80 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 811.99 Mn
10 Hyperion Defi 44.93 Mn 35.29 Mn 357,693.00 9.64 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 9.64 Mn
Mar 31, 2026 7.40 Mn
Dec 31, 2025 6.44 Mn
Sep 30, 2025 8.20 Mn
Jun 30, 2025 7.53 Mn
Mar 31, 2025 3.93 Mn
Dec 31, 2024 2.12 Mn
Sep 30, 2024 7.20 Mn
Jun 30, 2024 2.30 Mn
Mar 31, 2024 7.98 Mn
Dec 31, 2023 14.85 Mn
Sep 30, 2023 20.70 Mn
Jun 30, 2023 17.50 Mn
Mar 31, 2023 18.50 Mn
Dec 31, 2022 22.86 Mn
Sep 30, 2022 17.40 Mn
Jun 30, 2022 21.51 Mn
Mar 31, 2022 26.72 Mn
Dec 31, 2021 19.46 Mn
Sep 30, 2021 13.50 Mn